Syon Capital’s Fulgent Genetics FLGT Stock Holding History

Syon Capital’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,546	Closed	-$287K	–	609
2024 Q4	$287K	Buy	+15,546	New	+$304K	0.03%	410

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Syon Capital's FLGT Position: Q1 2025 in Review

Syon Capital sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 15,546 shares — an estimated $287K sold.

Syon Capital first reported a position in FLGT in Q4 2024 and held it in 1 quarter. The position peaked at $287K in Q4 2024. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

Syon Capital reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
Syon Capital sold 15,546 Fulgent Genetics shares in Q1 2025, an estimated $287K.
Syon Capital first reported a position in Fulgent Genetics in Q4 2024 and held it in 1 quarter.
Syon Capital's Fulgent Genetics position peaked at $287K in Q4 2024.
176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Syon Capital's 13F filing for Q1 2025, filed 15 May 2025.